Aurinia Pharmaceuticals Inc. |
Director |
Common Shares |
24.8K |
$209K |
$8.43 |
Nov 21, 2024 |
Direct |
SANGAMO THERAPEUTICS, INC |
Director |
Common Stock |
77.1K |
$46.3K |
$0.60 |
Jun 4, 2024 |
Direct |
Emergent BioSolutions Inc. |
EVP, Chief Medical Officer |
Common Stock |
11.9K |
$21.6K |
$1.82 |
May 7, 2021 |
Direct |
Quince Therapeutics, Inc. |
Chief Medical Officer |
Employee Stock Option (right to buy) |
225K |
|
|
Feb 1, 2023 |
Direct |
Skye Bioscience, Inc. |
Director |
Stock Option (Right to Buy) |
70K |
|
|
Oct 28, 2024 |
Direct |
SANGAMO THERAPEUTICS, INC |
Director |
Stock Option (Right to Buy) |
50K |
|
|
Jun 4, 2024 |
Direct |
Skye Bioscience, Inc. |
Director |
Director Stock Option (Right to Buy) |
40K |
|
|
Jul 2, 2024 |
Direct |
Talaris Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
20.5K |
|
|
Jun 13, 2023 |
Direct |
Context Therapeutics Inc. |
Director |
Stock Option (right to buy) |
19.3K |
|
|
Sep 4, 2024 |
Direct |
Aurinia Pharmaceuticals Inc. |
Director |
Director Stock Option (right to buy) |
18.6K |
|
|
Nov 21, 2024 |
Direct |
ACCELERON PHARMA INC |
Director |
Common Stock |
0 |
|
$29.37 |
Nov 19, 2021 |
Direct |
ACCELERON PHARMA INC |
Director |
Option to Purchase Common Stock |
0 |
|
|
Nov 19, 2021 |
Direct |
ANTARES PHARMA, INC. |
Director |
Common Stock |
0 |
|
$5.60 |
May 24, 2022 |
Direct |
ANTARES PHARMA, INC. |
Director |
Stock Option (right to buy) |
0 |
|
|
May 24, 2022 |
Direct |
Aurinia Pharmaceuticals Inc. |
Director |
Restricted Stock Units |
0 |
|
|
Nov 8, 2024 |
Direct |